Document:

Exhibit 10.6

 

UNDERWRITERS
WARRANTS PURCHASE AGREEMENT

 

THIS UNDERWRITERS WARRANTS
PURCHASE AGREEMENT, effective as of ___ _, 2021 (as it may from time to time be amended, this “Agreement”), is entered
into by and between CENAQ Energy Corp., a Delaware corporation (the “Company”), and Imperial Capital LLC as representative
of several underwriters (the “Purchaser”).

 

WHEREAS, the Company
intends to consummate a public offering of the Company’s units (the “Public Offering”), each unit
consisting of one share of the Company’s Class A common stock, par value $0.0001 per share (a “Share”), and
three-quarters of one redeemable warrant, each whole warrant exercisable for one Share at an exercise price of $11.50 per Share, as
set forth in the Company’s registration statement on Form S-1 related to the Public Offering (the “Registration
Statement”); and

 

WHEREAS, the Purchaser has
agreed to purchase from the Company an aggregate of 1,500,000 warrants (or up to 1,725,000 warrants if the over-allotment option in connection
with the Public Offering is exercised in full) (the “Underwriters Warrants”), each whole Underwriters Warrant entitling
the holder to purchase one Share at an exercise price of $11.50 per Share.

 

NOW, THEREFORE, in consideration
of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Article
I.

Authorization, Purchase and Sale; Terms of

the UNDERWRITERS Warrants.

 

Section 1.01 Authorization
of the Underwriters Warrants. The Company has duly authorized the issuance and sale of the Underwriters Warrants to the Purchaser.

 

Section 1.02 Purchase and
Sale of the Sponsor Warrants.

 

(a) As payment in full for the
1,500,000 Underwriters Warrants being purchased under this Agreement, Purchaser shall pay $1,500,000 (the “Purchase Price”),
by wire transfer of immediately available funds or by such other method as may be reasonably acceptable to the Company, to the trust account
(the “Trust Account”) at a financial institution to be chosen by the Company, maintained by J.P. Morgan Chase Bank,
N.A. with Continental Stock Transfer & Trust Company acting as trustee, at least one (1) business day prior to the date of effectiveness
of the Registration Statement.

 

(b) In the event that the over-allotment
option is exercised in full or in part, Purchaser shall purchase up to an additional 225,000 Underwriters Warrants (the “Additional
Underwriters Warrants”), in the same proportion as the amount of the over-allotment option that is exercised, and simultaneously
with such purchase of Additional Underwriters Warrants, as payment in full for the Additional Underwriters Warrants being purchased hereunder,
and at least one (1) business day prior to the closing of all or any portion of the over-allotment option, Purchaser shall pay $1.00 per
Additional Underwriters Warrant, up to an aggregate amount of approximately $225,000, by wire transfer of immediately available funds
or by such other method as may be reasonably acceptable to the Company, to the Trust Account.

 

(c) The closing of the purchase
and sale of the Underwriters Warrants shall take place simultaneously with the closing of the Public Offering (the “Initial Closing
Date”). The closing of the purchase and sale of the Additional Underwriters Warrants, if applicable, shall take place simultaneously
with the closing of all or any portion of the over-allotment option (such closing date, together with the Initial Closing Date, the “Closing
Dates” and each, a “Closing Date”).

 

     

     

    

 

Section 1.03 Terms of the Underwriters Warrants.

 

(a) The Underwriters Warrants
shall have their terms set forth in a Warrant Agreement to be entered into by the Company and a warrant agent, in connection with the
Public Offering (a “Warrant Agreement”).

 

(b) At or prior to the time
of the Initial Closing Date, the Company and the Purchaser shall enter into a registration rights agreement (the “Registration
Rights Agreement”) pursuant to which the Company will grant certain registration rights to the Purchaser relating to the Underwriters
Warrants and the Shares underlying the Underwriters Warrants.

 

Article
II.

Representations and Warranties of the Company

 

As a material inducement to
the Purchaser to enter into this Agreement and purchase the Underwriters Warrants, the Company hereby represents and warrants to the Purchaser
(which representations and warranties shall survive the Closing Dates) that:

 

Section 2.01 Organization
and Corporate Power. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State
of Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have
a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses all requisite
corporate power and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.

 

Section 2.02 Authorization;
No Breach.

 

(a) The execution, delivery
and performance of this Agreement and the Underwriters Warrants have been duly authorized by the Company as of the Closing Dates. This
Agreement constitutes a valid and binding obligation of the Company, enforceable in accordance with its terms, subject to bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’
rights and to general equitable principles (whether considered in a proceeding in equity or law). Upon issuance in accordance with, and
payment pursuant to, the terms of the Warrant Agreement and this Agreement, the Underwriters Warrants will constitute valid and binding
obligations of the Company, enforceable in accordance with their terms as of the Closing Dates subject to bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’ rights and to
general equitable principles (whether considered in a proceeding in equity or law).

 

(b) The execution and delivery
by the Company of this Agreement and the Underwriters Warrants, the issuance and sale of the Underwriters Warrants, the issuance of the
Shares upon exercise of the Underwriters Warrants and the fulfillment of, and compliance with, the respective terms hereof and thereof
by the Company, do not and will not as of the Closing Dates (a) conflict with or result in a breach of the terms, conditions or provisions
of, (b) constitute a default under, (c) result in the creation of any lien, security interest, charge or encumbrance upon the Company’s
capital stock or assets under, (d) result in a violation of, or (e) require any authorization, consent, approval, exemption or other action
by or notice or declaration to, or filing with, any court or administrative or governmental body or agency pursuant to (i) the certificate
of incorporation or the bylaws of the Company (in effect on the date hereof or as may be amended prior to completion of the contemplated
Public Offering), (ii) any material law, statute, rule or regulation to which the Company is subject, or (iii) any agreement, order, judgment
or decree to which the Company is subject, except for any filings required after the date hereof under federal or state securities laws,
except with respect to clauses (ii) and (iii) above, where such default, violation or conflict would not reasonably be expected to have
a material adverse effect on the financial condition, operating results or assets of the Company.

 

    2

     

    

 

Section 2.03 Title to Securities.
Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Shares issuable upon exercise
of the Underwriters Warrants will be duly and validly issued, fully paid and nonassessable. Upon issuance in accordance with, and payment
pursuant to, the terms hereof and the Warrant Agreement, the Purchaser will have good title to the Underwriters Warrants and the Shares
issuable upon exercise of such Underwriters Warrants, free and clear of all liens, claims and encumbrances of any kind, other than (i)
transfer restrictions hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions under federal and state
securities laws, and (iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.

 

Section 2.04 Governmental
Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is required
in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company of any
other transactions contemplated hereby.

 

Article
III.

Representations and Warranties of the Purchaser

 

As a material inducement to
the Company to enter into this Agreement and issue and sell the Underwriters Warrants to the Purchaser, the Purchaser hereby represents
and warrants to the Company (which representations and warranties shall survive the Closing Dates) that:

 

Section 3.01 Organization
and Requisite Authority. The Purchaser possesses all requisite power and authority necessary to carry out the transactions contemplated
by this Agreement.

 

Section 3.02 Authorization;
No Breach.

 

(a) This Agreement constitutes
a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’ rights and to
general equitable principles (whether considered in a proceeding in equity or law).

 

(b) The execution and delivery
by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser does not and shall not
as of the Closing Dates conflict with or result in a breach by the Purchaser of the terms, conditions or provisions of any agreement,
instrument, order, judgment or decree to which the Purchaser is subject.

 

Section 3.03 Investment
Representations.

 

(a) The Purchaser is acquiring
the Underwriters Warrants and, upon exercise of the Underwriters Warrants, the Shares issuable upon such exercise (collectively, the “Securities”),
for the Purchaser’s own account, for investment purposes only and not with a view towards, or for resale in connection with, any
public sale or distribution thereof in violation of the Securities Act of 1933, as amended (the “Securities Act”).

 

(c) The Purchaser understands
that the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration requirements of
the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchaser’s
compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the availability of such exemptions
and the eligibility of the Purchaser to acquire such Securities.

 

(d) The Purchaser did not enter
into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule 502(c) under the Securities
Act.

 

    3

     

    

 

(e) The Purchaser has been furnished
with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the
Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to ask questions of the executive
officers and directors of the Company. The Purchaser understands that its investment in the Securities involves a high degree of risk
and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect
to the acquisition of the Securities.

 

(f) The Purchaser understands
that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation
or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser nor have such authorities
passed upon or endorsed the merits of the offering of the Securities.

 

(g) The Purchaser understands
that: (a) the Securities have not been and are not being registered under the Securities Act or any state securities laws, and may not
be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold in reliance on an exemption
therefrom; and (b) except as specifically set forth in the Registration Rights Agreement, neither the Company nor any other person is
under any obligation to register the Securities under the Securities Act or any state securities laws or to comply with the terms and
conditions of any exemption thereunder. In this regard, the Purchaser understands that the Securities and Exchange Commission has taken
the position that promoters or affiliates of a blank check company and their transferees, both before and after an initial business combination,
are deemed to be “underwriters” under the Securities Act when reselling the securities of a blank check company. Based on
that position, Rule 144 adopted pursuant to the Securities Act would not be available for resale transactions of the Securities despite
technical compliance with the certain requirements of such Rule, and the Securities can be resold only through a registered offering or
in reliance upon another exemption from the registration requirements of the Securities Act.

 

(h) The Purchaser has such knowledge
and experience in financial and business matters, knowledge of the high degree of risk associated with investments in the securities of
companies in the development stage such as the Company, is capable of evaluating the merits and risks of an investment in the Securities
and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder for an indefinite period
of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and will have no current or anticipated
future needs for liquidity which would be jeopardized by the investment in the Securities. The Purchaser can afford a complete loss of
its investments in the Securities.

 

(i) The Purchaser understands
that the Private Placement Warrants shall bear the legend substantially in the form set forth in the Warrant Agreement.

 

Article
IV.

Conditions of the Purchaser’s Obligations

 

The obligations of the Purchaser
to purchase and pay for the Underwriters Warrants are subject to the fulfillment, on or before the Closing Dates, of each of the following
conditions:

 

Section 4.01 Representations
and Warranties. The representations and warranties of the Company contained in Article II shall be true and correct at and as of the
Closing Dates as though then made.

 

Section 4.02 Performance.
The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by it on or before the Closing Dates.

 

Section 4.03 No Injunction.
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or the
Warrant Agreement.

 

    4

     

    

 

Section 4.04 Warrant Agreement
and Registration Rights Agreement. The Company shall have entered into the Warrant Agreement and the Registration Rights Agreement
on terms satisfactory to the Purchaser.

 

Article
V.

Conditions of the Company’s Obligations

 

The obligations of the Company
to the Purchaser under this Agreement are subject to the fulfillment, on or before the Closing Dates, of each of the following conditions:

 

Section 5.01Representations
and Warranties. The representations and warranties of the Purchaser contained in Article III shall be true and correct at and as of
the Closing Dates as though then made.

 

Section 5.02 Performance.
The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by the Purchaser on or before the Closing Dates.

 

Section 5.03 No Injunction.
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or the
Warrant Agreement.

 

Section 5.04 Registration
Rights Agreement. The Purchaser shall have entered into the Registration Rights Agreement.

 

Article
VI.

Termination

 

This Agreement may be terminated
at any time after September 30, 2021 upon the election by either the Company or the Purchaser upon written notice to the other party,
if the closing of the Public Offering does not occur prior to such date.

 

Article
VII.

Survival of Representations and Warranties

 

All of the representations and warranties contained
herein shall survive the Closing Dates.

 

Article
VIII.

Definitions

 

Terms used but not otherwise
defined in this Agreement shall have the meaning assigned to such terms in the Registration Statement.

 

    5

     

    

 

Article
IX.

Miscellaneous

 

Section 9.01 Successors
and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf
of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed
or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement, other than assignments
by the Purchaser to affiliates thereof.

 

Section 9.02 Severability.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective
only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

Section 9.03 Counterparts.
This Agreement may be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than one
party, but all such counterparts taken together shall constitute one and the same agreement.

 

Section 9.04 Descriptive
Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive
part of this Agreement. The use of the word “including” in this Agreement shall be by way of example rather than by limitation.

 

Section 9.05 Governing
Law. This Agreement shall be deemed to be a contract made under the laws of the State of Texas and for all purposes shall be construed
in accordance with the internal laws of the State of Texas.

 

Section 9.06 Amendments.
This letter agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by
all parties hereto.

 

[Signature page follows]

 

    6

     

    

 

IN WITNESS WHEREOF, the parties
hereto have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 	 
	 	CENAQ ENERGY CORP.
	 	 	               
	 	By:	  
	 	Name: 	Michael J. Mayell
	 	Title:	President

 

	 	UNDERWRITERS:
	 	 
	 	Imperial Capital, LLC
	 	 	 
	 	By:	 
	 	 	Name:  	Chris Shepard
	 	 	Title: 	Executive Vice President

 

[Signature Page to Underwriters Warrant Purchase
Agreement]Exhibit 10.9

 

__ __, 2021

  

Imperial Capital, LLC

10100 Santa Monica Boulevard, Suite 2400

Los Angeles, California 90067

 

Re: Initial Public Offering

  

This letter agreement (this “Letter
Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting
Agreement”) to be entered into by and between CENAQ Energy Corp., a Delaware corporation (the
“Company”), and Imperial Capital, LLC, as representative (the “Representative”) of the several
underwriters (each, an “Underwriter” and collectively the “Underwriters”), relating to an
underwritten initial public offering (the “Public Offering”), of 15,000,000 of the Company’s units
(including up to 2,250,000 units that may be purchased to cover over-allotments, if any) (the “Units”), each
comprised of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Common
Stock”), and three-quarters of one redeemable warrant (the “Public Warrants”). Each whole warrant
entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment. The Units
shall be sold in the Public Offering pursuant to a registration statement on Form S-1 and prospectus (the
“Prospectus”) filed by the Company with the Securities and Exchange Commission (the
“Commission”), and the Company shall apply to have the Units listed on the NASDAQ Capital Market. Certain
capitalized terms used herein are defined in paragraph 4 hereof.

 

The Underwriters have committed to purchase an
aggregate of 1,500,000 private placement warrants (or 1,725,000 warrants if the over-allotment option is exercised in full) on terms identical
to the Public Warrants at a price of $1.00 per whole warrant (“Private Placement Warrants”).

 

The Company also agreed to issue to the Underwriters
and/or its designees, 165,000 shares of Common Stock (or 189,750 shares if the Underwriters exercise their over-allotment option in full)
upon the consummation of the Public Offering (“Representative Shares”).

 

The Underwriters hereby agree as follows:

 

1. If the Company seeks stockholder
approval of a proposed Business Combination, then in connection with such proposed Business Combination, they shall (i) vote any shares
of Common Stock owned by the Underwriters (including the Representative Shares), in favor of any proposed Business Combination and (ii)
not redeem any shares of Common Stock owned by them in connection with such stockholder approval.

 

2. The Underwriters acknowledge
that they have no right, title, interest or claim of any kind in or to any monies held in the Trust Account or any other asset of the
Company as a result of any liquidation of the Company. The Underwriters hereby further waive any redemption rights they may have in connection
with the consummation of a Business Combination, including, without limitation, any such rights available in the context of a stockholder
vote to approve such Business Combination or in the context of a tender offer made by the Company to purchase shares of Common Stock.

 

     

     

    

 

3. (a) The Underwriters agree
that they shall not Transfer any Representative Shares until the earlier of (A) six months year after the completion of the Company’s
initial Business Combination or (B) subsequent to the Business Combination, (x) if the last sale price of the Common Stock equals or exceeds
$12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days
within any 30-trading day period commencing at least 75 days after the Company’s initial Business Combination or (y) the date on
which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in
all of the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities or other property
(the “Representative Shares Lock-up Period”).

 

(b) The Underwriters agree
that they shall not Transfer any Private Placement Warrants (or shares of Common Stock issued or issuable upon the exercise of the Private
Placement Warrants), until 30 days after the completion of a Business Combination (the “Private Placement Warrants Lock-up Period”
and, together with the Representative Shares Lock-up Period, the “Lock-up Periods”).

 

(c) Notwithstanding the provisions
set forth in paragraphs 7(a) and (b), Transfers of the Representative Shares, Private Placement Warrants and shares of Common Stock issued
or issuable upon the exercise or conversion of the Private Placement Warrants, and that are held by the Underwriters or any of their permitted
transferees (that have complied with this paragraph 7(c)), are permitted (a) to the Underwriters’ officers, directors and any affiliates
or family members of any of the Underwriters’ officers and directors; (b) transfers by private sales or transfers made in connection
with the consummation of a Business Combination at prices no greater than the price at which the securities were originally purchased;
(c) transfers in the event of the Company’s liquidation prior to the completion of an initial Business Combination; (d) transfers
by virtue of the laws of the State of Delaware; and (e) in the event of the Company’s liquidation, merger, capital stock exchange,
reorganization or other similar transaction which results in all of the Company’s stockholders having the right to exchange their
shares of Common Stock for cash, securities or other property subsequent to the completion of the Company’s initial Business Combination;
provided, however, that in the case of clauses (a) through (e), these permitted transferees must enter into a written agreement agreeing
to be bound by the restrictions herein.

   

4. As used herein, (i) “Business
Combination” shall mean a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination, involving the Company and one or more businesses; (ii) “Public Stockholders” shall mean the holders of
securities issued in the Public Offering; (iii) “Trust Account” shall mean the trust account into which a portion of
the net proceeds of the Public Offering and the sale of the Private Placement Warrants shall be deposited; and (iv) “Transfer”
shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise
dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation
with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as
amended, and the rules and regulations of the Commission promulgated thereunder with respect to, any security, (b) entry into any swap
or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether
any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement of any intention
to effect any transaction specified in clause (a) or (b).

  

5. Except for the Underwriting
Agreement, this Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter
hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the
extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed,
amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument
executed by all parties hereto.

 

6. No party hereto may assign
either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the other
parties. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign
any interest or title to the purported assignee. This Letter Agreement shall be binding on the Underwriters and their respective successors,
heirs and assigns and permitted transferees.

 

7. Nothing in this Letter
Agreement shall be construed to confer upon, or give to, any person or corporation other than the parties hereto any right, remedy or
claim under or by reason of this Letter Agreement or of any covenant, condition, stipulation, promise or agreement hereof. All covenants,
conditions, stipulations, promises and agreements contained in this Letter Agreement shall be for the sole and exclusive benefit of the
parties hereto and their successors, heirs, personal representatives and assigns and permitted transferees.

 

8. This Letter Agreement
may be executed in any number of original or electronic counterparts and each of such counterparts shall for all purposes be deemed to
be an original, and all such counterparts shall together constitute but one and the same instrument.

 

    2

     

    

 

9. This Letter Agreement
shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability
of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision,
the parties hereto intend that there shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid
or unenforceable provision as may be possible and be valid and enforceable.

 

10. This Letter Agreement
shall be governed by and construed and enforced in accordance with the laws of the State of Texas, without giving effect to conflicts
of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i) all agree
that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced
in the courts of Houston, in the State of Texas, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall
be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.

 

11. Any notice, consent or
request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent by
express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or electronic transmission.

 

12. This Letter Agreement
shall terminate on the earlier of (i) the expiration of the Lock-up Periods or (ii) the liquidation of the Company; provided, however,
that this Letter Agreement shall earlier terminate in the event that the Public Offering is not consummated and closed by December 31,
2021.

 

	CENAQ Energy Corp.	 
	 	 	 
	By:	 	 
	Name:	Michael J. Mayell	 
	Title:	
    President

    
	 
	 	 	 
	Imperial Capital, LLC, as Representative of the Underwriters
	 	 	 
	By:	 	 
	Name:	Chris Shepard	 
	Title:	Executive Vice President	 

 

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]